MedPath

Solarmal: Solar energy for malaria elimination.

Conditions
MalariaVector control
Registration Number
NL-OMON22265
Lead Sponsor
Wageningen University Fund
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30000
Inclusion Criteria

Every resident of Rusinga Island, Mbita District, Nyanza Province, Western Kenya, will be eligible for inclusion in the study.

Exclusion Criteria

N/A

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Confirmed clinical malaria incidence (fever plus positive RDT) and malaria parasitaemia (positive RDT with or without clinical symptoms tested in a randomly selected 10% of the population every 4 months).
Secondary Outcome Measures
NameTimeMethod
Plasmodium antibodies tested using PCR, entomological inoculation rate, community perception and acceptance of the intervention.
© Copyright 2025. All Rights Reserved by MedPath